Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

B-Cell CLL/lymphoma 2 (BCL2) (Middle Region) Peptid

BCL2 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN973780
  • Target Alle Bcl-2 (BCL2) Produkte
    Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    • 12
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    ALSPVPPVVH LTLRQAGDDF SRRYRRDFAE MSSQLHLTPF TARGRFATVV
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-BCL2 Antibody(ARP58872_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
    Synonyme
    Bcl-2 Peptide, PPP1R50 Peptide, bcl-2 Peptide, AW986256 Peptide, C430015F12Rik Peptide, D630044D05Rik Peptide, D830018M01Rik Peptide, BCL-2 Peptide, Bcl2 Peptide, BCL2, apoptosis regulator Peptide, B cell leukemia/lymphoma 2 Peptide, B-cell CLL/lymphoma 2a Peptide, B-cell CLL/lymphoma 2 protein Peptide, BCL2 Peptide, Bcl2 Peptide, bcl2a Peptide, BCL-2 Peptide
    Hintergrund
    This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants, produced by alternate splicing, differ in their C-terminal ends.

    Alias Symbols: Bcl-2, PPP1R50

    Protein Interaction Partner: BAD,BAD,BAX,BBC3,BCL2L11,BID,BIK,BIK,BMF,BNIPL,HRK,HRK,RHEB,MOAP1,ATP2A2,BAD,BAG1,BAG3,BAG4,BAK1,BAX,BBC3,BCAP31,BCL2,BCL2L1,BCL2L10,BCL2L11,BCL2L14,BCLAF1,BECN1,BFAR,BID,BIK,BLK,BMF,BNIP1,BNIP2,BNIP3,BNIP3L,BNIPL,CASP3,CASP8,CDK2,CPT1A,CYCS,FKBP8,HRAS,HR

    Protein Size: 239
    Molekulargewicht
    26 kDa
    Gen-ID
    596
    NCBI Accession
    NM_000633, NP_000624
    UniProt
    P10415
Sie sind hier:
Kundenservice